Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts
2022

Inhibition of miR-497 Reduces Oral Submucous Fibrosis

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): Huang Jie, Zhang Huang, Fan Xusheng, Guo Junxin

Primary Institution: Hangzhou First People’s Hospital Affiliated to Medical College of Zhejiang University

Hypothesis

This study aimed to evaluate the effect and detailed mechanism of miR-497 in arecoline-induced oral submucous fibrosis in buccal mucosal fibroblasts.

Conclusion

Inhibition of miR-497 may protect against oral submucous fibrosis by inhibiting myofibroblast transdifferentiation through the TGF-β1/Smads signaling pathway.

Supporting Evidence

  • miR-497 inhibition suppressed the contractility, migration, and invasiveness of AR-induced buccal mucosal fibroblasts.
  • Overexpression of miR-497 produced the opposite effects.
  • miR-497 inhibition down-regulated the expression level of collagen I and α-SMA in AR-exposed buccal mucosal fibroblasts.
  • TGF-β1 expression and Smad2 and Smad3 phosphorylation were repressed after miR-497 inhibition.

Takeaway

This study found that blocking a tiny molecule called miR-497 can help stop a disease that makes it hard to open your mouth by preventing certain cells from changing into a harmful form.

Methodology

The study involved silencing or overexpressing miR-497 in buccal mucosal fibroblasts and assessing contractility, migration, and invasiveness using various assays.

Limitations

Only one cell line was used, and the study lacked in-vivo experiments to validate the findings.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.3290/j.ohpd.b3276183

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication